Hypoxic up-regulation of triosephosphate isomerase expression in mouse brain capillary endothelial cells. 2004

Ryoichi Yamaji, and Kayoko Fujita, and Isao Nakanishi, and Kaori Nagao, and Mikihiko Naito, and Takashi Tsuruo, and Hiroshi Inui, and Yoshihisa Nakano
Division of Applied Biological Chemistry, Graduate School of Agriculture and Biological Sciences, Osaka Prefecture University, Sakai, Osaka 5998531, Japan. yamaji@biochem.osakafu-u.ac.jp

A protein with a molecular mass of 27kDa was induced by hypoxia in a mouse brain capillary endothelial cell line and identified as triosephosphate isomerase (TPI) by amino-terminal sequencing. Hypoxia caused an elevation of the TPI protein level, concomitant with an increase of the TPI mRNA level. However, hypoxia resulted in an insufficient elevation of TPI activity level, compared to an increase of TPI protein level. When cells expressing the recombinant TPI protein with histidine tag were exposed to hypoxia and the TPI protein was affinity-purified, the catalytic activity (specific activity) of the TPI protein purified from hypoxic cells was substantially lower than that obtained from normoxic cells. In addition, three TPI isoforms with an electrophoretic multiplicity were found; two of the three isoforms were substantially increased in response to the hypoxia, but the level of the most acidic isoform was barely changed. The induction of TPI gene expression by hypoxia was suppressed by (1) a chelator of intracellular Ca(2+), (2) a blocker of non-selective cation channels, (3) a blocker of Na(+)/Ca(2+) exchangers, (4) an inhibitor of Ca(2+)/calmodulin-dependent protein kinases, and (5) an inhibitor of c-jun/AP-1 activation.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002614 Chelating Agents Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. Chelating Agent,Chelator,Complexons,Metal Antagonists,Chelators,Metal Chelating Agents,Agent, Chelating,Agents, Chelating,Agents, Metal Chelating,Antagonists, Metal,Chelating Agents, Metal
D003035 Cobalt A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis. Cobalt-59,Cobalt 59
D003474 Curcumin A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes. 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-,Curcumin Phytosome,Diferuloylmethane,Mervia,Turmeric Yellow,Phytosome, Curcumin,Yellow, Turmeric

Related Publications

Ryoichi Yamaji, and Kayoko Fujita, and Isao Nakanishi, and Kaori Nagao, and Mikihiko Naito, and Takashi Tsuruo, and Hiroshi Inui, and Yoshihisa Nakano
August 2016, Biochemical and biophysical research communications,
Ryoichi Yamaji, and Kayoko Fujita, and Isao Nakanishi, and Kaori Nagao, and Mikihiko Naito, and Takashi Tsuruo, and Hiroshi Inui, and Yoshihisa Nakano
January 1999, International journal of molecular medicine,
Ryoichi Yamaji, and Kayoko Fujita, and Isao Nakanishi, and Kaori Nagao, and Mikihiko Naito, and Takashi Tsuruo, and Hiroshi Inui, and Yoshihisa Nakano
December 1996, Stroke,
Ryoichi Yamaji, and Kayoko Fujita, and Isao Nakanishi, and Kaori Nagao, and Mikihiko Naito, and Takashi Tsuruo, and Hiroshi Inui, and Yoshihisa Nakano
March 2004, The Journal of biological chemistry,
Ryoichi Yamaji, and Kayoko Fujita, and Isao Nakanishi, and Kaori Nagao, and Mikihiko Naito, and Takashi Tsuruo, and Hiroshi Inui, and Yoshihisa Nakano
August 1989, Molecular and cellular biochemistry,
Ryoichi Yamaji, and Kayoko Fujita, and Isao Nakanishi, and Kaori Nagao, and Mikihiko Naito, and Takashi Tsuruo, and Hiroshi Inui, and Yoshihisa Nakano
May 2004, Pflugers Archiv : European journal of physiology,
Ryoichi Yamaji, and Kayoko Fujita, and Isao Nakanishi, and Kaori Nagao, and Mikihiko Naito, and Takashi Tsuruo, and Hiroshi Inui, and Yoshihisa Nakano
August 2018, American journal of physiology. Cell physiology,
Ryoichi Yamaji, and Kayoko Fujita, and Isao Nakanishi, and Kaori Nagao, and Mikihiko Naito, and Takashi Tsuruo, and Hiroshi Inui, and Yoshihisa Nakano
January 2007, Journal of biomedical science,
Ryoichi Yamaji, and Kayoko Fujita, and Isao Nakanishi, and Kaori Nagao, and Mikihiko Naito, and Takashi Tsuruo, and Hiroshi Inui, and Yoshihisa Nakano
July 1999, The Journal of pharmacy and pharmacology,
Ryoichi Yamaji, and Kayoko Fujita, and Isao Nakanishi, and Kaori Nagao, and Mikihiko Naito, and Takashi Tsuruo, and Hiroshi Inui, and Yoshihisa Nakano
February 2009, Molecular oncology,
Copied contents to your clipboard!